← FDA DRUG APPROVALS

FDA NDA · NDA009436

ACYLANID

Sponsor: NOVARTIS

APPLICATION
NDA009436
TYPE
NDA
LATEST ACTION
1981-01-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACYLANIDDiscontinued
ACETYLDIGITOXIN 0.1MG · TABLET · ORAL

Approval history

1981-01-06Manufacturing (CMC) · Supplement 9 · standardAP
1978-04-27Manufacturing (CMC) · Supplement 6 · standardAP
1977-08-02Manufacturing (CMC) · Supplement 7 · standardAP
1976-04-16Manufacturing (CMC) · Supplement 5 · standardAP
1975-04-24Manufacturing (CMC) · Supplement 4 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →